Member Info for Hubstar

I would expect any offer to be 4 to 5 times higher than the current market cap ,its not certain but i think likely this could happen.

There is a rumour that a Singapore based Hedge Fund is circling Futura ,that rumour has been around a few weeks now ,and given the company entry into Asia who knows (there could be some truth to it ) .

Gold G, i am not a peddler ,i have given commentary on both these shares recently , as Godo mentioned ORR have multiple opportunities for growth and re-rating and not the usual rubbish you see in the junior space ( and good management ) As for Futura Medical ,they are currently expanding in Asia which is a huge market and should see a rapid and large increase in revenues ( and are a T/O target ) .Both of these shares could be star shares for 2026 imvho

I wonder if there is some news brewing here ? just before 9am this morning they were bidding 1.31p for 500k of shares and was briefly in auction,i have a prediction this is being primed for a T/O .

Godo, nice summary of where Oriole are in the cycle :-) i have added to my position a few times and expect a positive 2026 ahead.

Both ORR and FUM could be large baggers in 2026 ( they were bidding 1.31p at FUM a short while ago for 500k shares - some news brewing IMO )

They are defo trying a shake out -- and PEEL still active

They are shaking the tree now by the look of it

Donald,wheres your troosers :-)

Magpie,,better to concentrate on the big market that Futura is about to launch into ???

Donald,if an RNS lands tomorrow stating they have the South Korea or Singapore patent secured you will see 4p very quick IMO

Imagine the size of the China market alone ,there are also other countries in Asia where Futura have Patents filed ,even a modest campaign in this region should bring a major uplift in revenue for the company.

Rns summary - 10th December 2025

Futura Medical PLC has received notice of patent allowance for its Eroxon product in China, securing protection until 2040 and enhancing its competitive position in a market with an estimated 50% prevalence of erectile dysfunction among 700 million adult males. This allowance adds to existing protection in Europe, Hong Kong, Taiwan, and the US, with further applications pending and a divisional patent planned for early 2026. The company is actively seeking partners in China to leverage this significant commercial opportunity.

Now going NT for volume buys over 300k....we might have a very tasty finish and open tomorrow IMO

Donald,think about the size of the chinese market alone for Futura,it will be transformational for Futura

Recent Rns summary :

Futura Medical PLC has received notice of patent allowance for its Eroxon product in China, securing protection until 2040 and enhancing its competitive position in a market with an estimated 50% prevalence of erectile dysfunction among 700 million adult males. This allowance adds to existing protection in Europe, Hong Kong, Taiwan, and the US, with further applications pending and a divisional patent planned for early 2026. The company is actively seeking partners in China to leverage this significant commercial opportunity.

The new management at FUM are confident of taking a huge market share in Asia ....it will transform the company to where it should have been a long time ago. And i also think Futura will be subject of a T/O at some point .

There is a chance this goes to 1.5p very soon -

I am expecting a lively close today when those late large reported buys show up .

Just quoted 1.38p for 3.2m shares ...there is a big background buyer hoovering up everything

Buzz...expect to see a few multi million buys pop up that were delayed from the open auction - circa 1.25p level

Laura,that shows a measure of confidence from the company management,they obviously believe the Asia market will be a game changer for the company and there is every reason to believe it will. A little effort in this region will reap big rewards in my opinion.